Howard W. Donnelly's most recent trade in Angiodynamic Inc was a trade of 20,541 Common Stock done . Disclosure was reported to the exchange on July 17, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Howard W. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 149,376 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Howard W. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,060 | 111,794 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Howard W. Donnelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2022 | 6,022 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Howard W. Donnelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.95 per share. | 20 Apr 2022 | 6,022 | 104,734 (0%) | 0% | 16.0 | 96,051 | Common Stock |
| Angiodynamic Inc | Howard W. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 5,738 | 98,712 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Howard W. Donnelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.64 per share. | 01 Apr 2021 | 5,726 | 96,595 (0%) | 0% | 14.6 | 83,829 | Common Stock |
| Angiodynamic Inc | Howard W. Donnelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 5,726 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Howard W. Donnelly | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.15 per share. | 01 Apr 2021 | 3,621 | 92,974 (0%) | 0% | 23.1 | 83,826 | Common Stock |
| Angiodynamic Inc | Howard W. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2020 | 15,323 | 90,869 (0%) | 0% | 0 | Common Stock |